Exotome

Optimizing cancer surgeries using dual-acting imaging and ablation agent

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location San Diego, CA, USA
  • Currency USD
  • Founded April 2019
  • Employees 4
  • Incorporation Type C-corp
  • Website exotome.us

Company Summary

Exo-413, developed at the laboratory of molecular imaging pioneer Prof. James Basilion at Case Western Reserve Univ. using over $2.5M of grants, is the world's only agent capable of both imaging and ablation of prostate cancer tumors. Exotome, founded by experienced clinical trial executives, is seeking $1.5M to advance to human studies. A Series A round of $5M will suffice to obtain Phase II data by 2023. Comparable exits are at $50M+ range.

Team

  • Business Development

    Senior healthcare executive with operational, legal and deal-making expertise developed in large healthcare corporations and as founder and CEO of healthcare startups.

    Wharton MBA

    Led $500M+ deals for Omnicell Inc., Edwards Lifesciences

    GM, Omnicell Germany ($30M sales, 130 employees)

    CEO of MicroMRI, imaging company merged with Bioclinica

    Attorney

  • Ari Aminetzah
    CEO

    A savvy Life Sciences executive and serial entrepreneur with more than 25 years of international broad leadership and management experience in both early and clinical-stage pharmaceutical, diagnostics and medical device companies.

    CBO, Tracer CRO

    Advisor to J&J Executive Board, Dutch government, McKinsey & Co.

    SVP Innovation, Crucell (sold to J&J for $2.7B (inc. prostate cancer vaccine)

    CEO, SPL (oncology imaging), sold to Bender Groupe

  • Prof. Go Van Dam
    CSO

    A surgeon from the Academic Medical Center in Groningen in the Netherlands, a pioneer and a world expert in the field of Optical imaging.

    Prof. of Surgery, Nuclear Medicine and Molecular Imaging

    Co-Founder of American and Intl. Societies of Image Guided Surgery

    155 publications inc. top 1% cited in NEJM

    Appointments at Harvard, NIH/NCI Mayo Clinic, UCSD

    CEO, Tracer CRO, the world's leading microdosing CRO

  • Co-Founder

    Professor of Radiology and Biomedical Engineering at Case Western Reserve has been in the field of optical molecular imaging since the early 1990s and has just retired as the president of the World Molecular Imaging Society.

    Prof. of Bioengineering, Pathology, CWRU

    Co-Founder: American Academy of Nanomedicine, World Molecular Imaging Society

    Previously consultant to Eli Lilly, Novartis, Variagenics, UBS Warburg

Advisors

  • Prof. Lee Ponsky, Chair, Dept. of Urology, CWRU
    Unconfirmed
    Eben Rosenthal, MD, PhD, Surgery/Radiology, Stanford Cancer Center
    Unconfirmed

Previous Investors

  • Jennifer Spohr, 3rd Frontier Fund, Ohio Development Program
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free